Published Date: 02 Feb 2024
Science journals and researchers are keeping a close eye on these people.
Read Full NewsFormer UK prime minister Rishi Sunak has called for a targeted prostate cancer screening program for men most at high risk of the disease, reviving a national debate on how to save more lives and tackle health inequalities ...
In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed ...
About half of women over 40 have dense breasts. The denser the breast tissue, the more difficult it is to spot cancer on a standard mammogram. Having dense breast tissue can make it harder to detect cancer and sometimes leads ...
Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients—and found a potential way to overcome that resistance.
1.
Gene therapies for BCG-unresponsive bladder cancer have high response rates.
2.
Children with cancer experience much less pain at home when using a pain monitoring app.
3.
Data indicate 1 in 3 US adults unaware of connection between HPV and cancers
4.
The hidden costs of cancer for young survivors are derailing their financial futures
5.
FDA approves rivanetin as the first-line treatment for lung cancer.
1.
Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective
2.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
3.
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
4.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
5.
Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Cancer- Q&A Session to Close the Gap
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
4.
Navigating the Complexities of Ph Negative ALL - Part I
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation